Note from June 29, 2020
Although we do not yet know how long the social distancing related to the Covid-19 pandemic will last, and regardless of the changes that had to be made in the evaluation of the June 2020 session in relation to what is provided for in this learning unit description, new learnig unit evaluation methods may still be adopted by the teachers; details of these methods have been - or will be - communicated to the students by the teachers, as soon as possible.
Although we do not yet know how long the social distancing related to the Covid-19 pandemic will last, and regardless of the changes that had to be made in the evaluation of the June 2020 session in relation to what is provided for in this learning unit description, new learnig unit evaluation methods may still be adopted by the teachers; details of these methods have been - or will be - communicated to the students by the teachers, as soon as possible.
4 credits
45.0 h + 15.0 h
Q1
Teacher(s)
Frédérick Raphaël (coordinator);
Language
French
Prerequisites
WFARM1008 conception du médicament
WFARM1231 chimie organique 2ième partie
WFARM1221 Biochimie
WFARM1232 Pharmacologie générale
WFARM1231 chimie organique 2ième partie
WFARM1221 Biochimie
WFARM1232 Pharmacologie générale
Main themes
The general theme is the structure - activity relationship of the drugs. Since this theme is broad, it has to be exemplified by selected topics: (i) chemical and physico-chemical properties of drugs in relationship with their pharmacokinetic and pharmacodynamic behavior (phototoxicity, in vitro and in vivo hydrolysis, charge (pKa), logP (Lipinski's rule), chirality) (ii) (ii) ligand - receptor interaction, with regard to physico-chemical properties : ature of the intermolecular interactions, types of targets (receptors, ion channels, enzymes, transporters, pumps), consequence of the binding of a xenobiotic on these targets (iii) drug discovery and optimization process, scope and limitation of the drug design techniques. The practical exercises allow students to establish themselves their own experimental plans in order to assign the structure of simple molecules (spot tests, derivatization, spectroscopy).
Content
The course is intended to be an in-depth description of typical examples of structure-activity relationships rather than an exhaustive coverage of the broad field of medicinal chemistry. For example, the classes of sulfonamides, NSAI agents, inhibitors of the conversion enzyme, chloroquine, etc. illustrate the relevance of pKa and logP parameters on the pharmacological and pharmacokinetic properties of these drugs. Beta-adrenergic, nicotinic, glutamate, insuline, and oestrogene receptors, calcium channels, Na+/K+ & H+/K+ ATPases allow to illustrate the effector - target molecular interaction. The classical and more recent developments of CNS drugs (e.g. opioids) are used to introduce drug design concepts.
Bibliography
Drug-like Properties: Concepts, Structure Design and Methods, 1st Edition from ADME to Toxicity Optimization Authors: Li Di Edward Kerns
The Practice of Medicinal Chemistry, Editors: Camille Wermuth David Aldous Pierre Raboisson Didier Rognan
The Practice of Medicinal Chemistry, Editors: Camille Wermuth David Aldous Pierre Raboisson Didier Rognan
Faculty or entity
FARM
